Brandtree

Who owns Engov?

Engov is owned by Hypera (Brazil, B3: HYPE3).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Key facts

Current owner
Hypera Pharma reported
Owned since
Not recorded
Previous owner
None recorded
Owner HQ
🇧🇷 Brazil, São Paulo
Origin
🇧🇷 Brazil
Category
Consumer healthOver-the-counter medicinePain relief
Parent ticker
B3: HYPE3
Last verified
· 1 sources

About Engov

Engov is a Hypera Pharma tablet for relieving headache, malaise, heartburn and nausea, sold in packs of six to 24 and marketed around nights out. The brand extended into Engov After, a canned drink with glucose, caffeine and mineral salts for recovery the next day, which Hypera made the official recovery drink of the tenth Rock in Rio festival.

Ownership timeline of Engov

  1. ? – present Hypera [1] reported

Where Engov sits in Hypera

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Engov sits in Hypera Tree of 8 brands under Hypera. Hypera Engov Benegrip Biotônico Fontoura Doril Epocler Estomazil and 2 more

Open the full Hypera ownership tree →

Other brands owned by Hypera in consumer health

See the full Hypera brand portfolio (8) →

Latest news about Engov

No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.

Headlines link to the original publisher. Brandtree does not reproduce article text.

Frequently asked questions

Who is the parent company of Engov?

The parent company of Engov is Hypera, a publicly listed company headquartered in Brazil.

Is Engov Brazilian?

Yes. Engov originated in Brazil and its owner, Hypera, is also headquartered in Brazil.

Is Engov still owned by Hypera?

Yes. As of 16 September 2026, Engov is still owned by Hypera. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.